DK 221 is a PD-L1 blocker with an IC 50 of 24.5 nM for inhibiting the binding of PD-L1 to PD-1 . DK 221 reduces the uptake of [ 18 F]DK222 in PD-L1 -positive tumor cells and mouse xenografts. DK 221 is applicable to research related to triple-negative breast cancer and melanoma.
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Melanoma | Products > Disease Areas > Triple-Negative Breast Cancer | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > PD-1/PD-L1
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.